Regeneron says antibody drug may speed recovery of patients with mild COVID-19

An experimental antibody treatment from Regeneron appears to help patients with mild cases of COVID-19 shake their symptoms sooner, reducing coronavirus levels in their bodies, according to early clinical results announced on Tuesday.